Skip to main content

Understanding Why Treatment Resistance Exists in Many Cancers

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

One of the biggest challenges that the medical community faces in fighting cancer is the treatment resistance phenomenon. Treatment resistance results in poor prognosis for patients due to the inability of available treatments to deliver meaningful beneficial changes in cancer progression. We discuss some of the mechanisms that have been studied as scientists search for a solution to treatment resistance in cancer patients.

Scientists are currently preoccupied with finding ways to overcome acquired resistance to treatment in various cancer types and subtypes. For instance, the team at Calidi Biotherapeutics Inc. (NYSE American: CLDI) is working to develop oncolytic virus therapies designed to equip the immune system with a…

Read More>>

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.34
-1.70 (-0.69%)
AAPL  315.32
-0.90 (-0.28%)
AMD  557.89
+11.17 (2.04%)
BAC  59.67
+0.42 (0.71%)
GOOG  355.03
-1.21 (-0.34%)
META  669.21
+37.73 (5.97%)
MSFT  385.10
+0.74 (0.19%)
NVDA  210.96
+8.18 (4.03%)
ORCL  140.64
-3.08 (-2.14%)
TSLA  407.76
+1.21 (0.30%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.